Medical Care
Global Artificial Intelligence (AI) in Pharmaceutical Market Research Report 2025
- Apr 07, 25
- ID: 167527
- Pages: 89
- Figures: 86
- Views: 34
The global market for Artificial Intelligence (AI) in Pharmaceutical was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence (AI) in Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence (AI) in Pharmaceutical.
The Artificial Intelligence (AI) in Pharmaceutical market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Intelligence (AI) in Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence (AI) in Pharmaceutical companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca LLC
Atomwise Inc
Bayer AG
Cloud Pharmaceuticals Inc
GNS Healthcare
IBM Watson
Merck & Co.
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer Inc.
Recursion Pharmaceuticals Inc.
XtalPi Inc
Segment by Type
Hardware
Software
Segment by Application
Pharmaceutical Company
Institute of Biology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence (AI) in Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence (AI) in Pharmaceutical.
The Artificial Intelligence (AI) in Pharmaceutical market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Intelligence (AI) in Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence (AI) in Pharmaceutical companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca LLC
Atomwise Inc
Bayer AG
Cloud Pharmaceuticals Inc
GNS Healthcare
IBM Watson
Merck & Co.
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer Inc.
Recursion Pharmaceuticals Inc.
XtalPi Inc
Segment by Type
Hardware
Software
Segment by Application
Pharmaceutical Company
Institute of Biology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hardware
1.2.3 Software
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Institute of Biology
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Perspective (2020-2031)
2.2 Global Artificial Intelligence (AI) in Pharmaceutical Growth Trends by Region
2.2.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Artificial Intelligence (AI) in Pharmaceutical Historic Market Size by Region (2020-2025)
2.2.3 Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Region (2026-2031)
2.3 Artificial Intelligence (AI) in Pharmaceutical Market Dynamics
2.3.1 Artificial Intelligence (AI) in Pharmaceutical Industry Trends
2.3.2 Artificial Intelligence (AI) in Pharmaceutical Market Drivers
2.3.3 Artificial Intelligence (AI) in Pharmaceutical Market Challenges
2.3.4 Artificial Intelligence (AI) in Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence (AI) in Pharmaceutical Players by Revenue
3.1.1 Global Top Artificial Intelligence (AI) in Pharmaceutical Players by Revenue (2020-2025)
3.1.2 Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Players (2020-2025)
3.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Artificial Intelligence (AI) in Pharmaceutical Revenue
3.4 Global Artificial Intelligence (AI) in Pharmaceutical Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Pharmaceutical Revenue in 2024
3.5 Global Key Players of Artificial Intelligence (AI) in Pharmaceutical Head office and Area Served
3.6 Global Key Players of Artificial Intelligence (AI) in Pharmaceutical, Product and Application
3.7 Global Key Players of Artificial Intelligence (AI) in Pharmaceutical, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Pharmaceutical Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Pharmaceutical Historic Market Size by Type (2020-2025)
4.2 Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Type (2026-2031)
5 Artificial Intelligence (AI) in Pharmaceutical Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Pharmaceutical Historic Market Size by Application (2020-2025)
5.2 Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Artificial Intelligence (AI) in Pharmaceutical Market Size (2020-2031)
6.2 North America Artificial Intelligence (AI) in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025)
6.4 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size (2020-2031)
7.2 Europe Artificial Intelligence (AI) in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025)
7.4 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size (2020-2031)
8.2 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2020-2025)
8.4 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size (2020-2031)
9.2 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025)
9.4 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size (2020-2031)
10.2 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025)
10.4 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca LLC
11.1.1 AstraZeneca LLC Company Details
11.1.2 AstraZeneca LLC Business Overview
11.1.3 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Introduction
11.1.4 AstraZeneca LLC Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.1.5 AstraZeneca LLC Recent Development
11.2 Atomwise Inc
11.2.1 Atomwise Inc Company Details
11.2.2 Atomwise Inc Business Overview
11.2.3 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Introduction
11.2.4 Atomwise Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.2.5 Atomwise Inc Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Introduction
11.3.4 Bayer AG Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.3.5 Bayer AG Recent Development
11.4 Cloud Pharmaceuticals Inc
11.4.1 Cloud Pharmaceuticals Inc Company Details
11.4.2 Cloud Pharmaceuticals Inc Business Overview
11.4.3 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Introduction
11.4.4 Cloud Pharmaceuticals Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.4.5 Cloud Pharmaceuticals Inc Recent Development
11.5 GNS Healthcare
11.5.1 GNS Healthcare Company Details
11.5.2 GNS Healthcare Business Overview
11.5.3 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Introduction
11.5.4 GNS Healthcare Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.5.5 GNS Healthcare Recent Development
11.6 IBM Watson
11.6.1 IBM Watson Company Details
11.6.2 IBM Watson Business Overview
11.6.3 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Introduction
11.6.4 IBM Watson Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.6.5 IBM Watson Recent Development
11.7 Merck & Co.
11.7.1 Merck & Co. Company Details
11.7.2 Merck & Co. Business Overview
11.7.3 Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Introduction
11.7.4 Merck & Co. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.7.5 Merck & Co. Recent Development
11.8 Microsoft Corporation
11.8.1 Microsoft Corporation Company Details
11.8.2 Microsoft Corporation Business Overview
11.8.3 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Introduction
11.8.4 Microsoft Corporation Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.8.5 Microsoft Corporation Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Introduction
11.9.4 Novartis AG Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.9.5 Novartis AG Recent Development
11.10 NVIDIA Corporation
11.10.1 NVIDIA Corporation Company Details
11.10.2 NVIDIA Corporation Business Overview
11.10.3 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Introduction
11.10.4 NVIDIA Corporation Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.10.5 NVIDIA Corporation Recent Development
11.11 Pfizer Inc.
11.11.1 Pfizer Inc. Company Details
11.11.2 Pfizer Inc. Business Overview
11.11.3 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Introduction
11.11.4 Pfizer Inc. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.11.5 Pfizer Inc. Recent Development
11.12 Recursion Pharmaceuticals Inc.
11.12.1 Recursion Pharmaceuticals Inc. Company Details
11.12.2 Recursion Pharmaceuticals Inc. Business Overview
11.12.3 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Introduction
11.12.4 Recursion Pharmaceuticals Inc. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.12.5 Recursion Pharmaceuticals Inc. Recent Development
11.13 XtalPi Inc
11.13.1 XtalPi Inc Company Details
11.13.2 XtalPi Inc Business Overview
11.13.3 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Introduction
11.13.4 XtalPi Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.13.5 XtalPi Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hardware
1.2.3 Software
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Institute of Biology
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Perspective (2020-2031)
2.2 Global Artificial Intelligence (AI) in Pharmaceutical Growth Trends by Region
2.2.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Artificial Intelligence (AI) in Pharmaceutical Historic Market Size by Region (2020-2025)
2.2.3 Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Region (2026-2031)
2.3 Artificial Intelligence (AI) in Pharmaceutical Market Dynamics
2.3.1 Artificial Intelligence (AI) in Pharmaceutical Industry Trends
2.3.2 Artificial Intelligence (AI) in Pharmaceutical Market Drivers
2.3.3 Artificial Intelligence (AI) in Pharmaceutical Market Challenges
2.3.4 Artificial Intelligence (AI) in Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence (AI) in Pharmaceutical Players by Revenue
3.1.1 Global Top Artificial Intelligence (AI) in Pharmaceutical Players by Revenue (2020-2025)
3.1.2 Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Players (2020-2025)
3.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Artificial Intelligence (AI) in Pharmaceutical Revenue
3.4 Global Artificial Intelligence (AI) in Pharmaceutical Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Pharmaceutical Revenue in 2024
3.5 Global Key Players of Artificial Intelligence (AI) in Pharmaceutical Head office and Area Served
3.6 Global Key Players of Artificial Intelligence (AI) in Pharmaceutical, Product and Application
3.7 Global Key Players of Artificial Intelligence (AI) in Pharmaceutical, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Pharmaceutical Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Pharmaceutical Historic Market Size by Type (2020-2025)
4.2 Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Type (2026-2031)
5 Artificial Intelligence (AI) in Pharmaceutical Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Pharmaceutical Historic Market Size by Application (2020-2025)
5.2 Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Artificial Intelligence (AI) in Pharmaceutical Market Size (2020-2031)
6.2 North America Artificial Intelligence (AI) in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025)
6.4 North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size (2020-2031)
7.2 Europe Artificial Intelligence (AI) in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025)
7.4 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size (2020-2031)
8.2 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2020-2025)
8.4 Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size (2020-2031)
9.2 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025)
9.4 Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size (2020-2031)
10.2 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025)
10.4 Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca LLC
11.1.1 AstraZeneca LLC Company Details
11.1.2 AstraZeneca LLC Business Overview
11.1.3 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Introduction
11.1.4 AstraZeneca LLC Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.1.5 AstraZeneca LLC Recent Development
11.2 Atomwise Inc
11.2.1 Atomwise Inc Company Details
11.2.2 Atomwise Inc Business Overview
11.2.3 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Introduction
11.2.4 Atomwise Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.2.5 Atomwise Inc Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Introduction
11.3.4 Bayer AG Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.3.5 Bayer AG Recent Development
11.4 Cloud Pharmaceuticals Inc
11.4.1 Cloud Pharmaceuticals Inc Company Details
11.4.2 Cloud Pharmaceuticals Inc Business Overview
11.4.3 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Introduction
11.4.4 Cloud Pharmaceuticals Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.4.5 Cloud Pharmaceuticals Inc Recent Development
11.5 GNS Healthcare
11.5.1 GNS Healthcare Company Details
11.5.2 GNS Healthcare Business Overview
11.5.3 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Introduction
11.5.4 GNS Healthcare Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.5.5 GNS Healthcare Recent Development
11.6 IBM Watson
11.6.1 IBM Watson Company Details
11.6.2 IBM Watson Business Overview
11.6.3 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Introduction
11.6.4 IBM Watson Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.6.5 IBM Watson Recent Development
11.7 Merck & Co.
11.7.1 Merck & Co. Company Details
11.7.2 Merck & Co. Business Overview
11.7.3 Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Introduction
11.7.4 Merck & Co. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.7.5 Merck & Co. Recent Development
11.8 Microsoft Corporation
11.8.1 Microsoft Corporation Company Details
11.8.2 Microsoft Corporation Business Overview
11.8.3 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Introduction
11.8.4 Microsoft Corporation Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.8.5 Microsoft Corporation Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Introduction
11.9.4 Novartis AG Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.9.5 Novartis AG Recent Development
11.10 NVIDIA Corporation
11.10.1 NVIDIA Corporation Company Details
11.10.2 NVIDIA Corporation Business Overview
11.10.3 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Introduction
11.10.4 NVIDIA Corporation Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.10.5 NVIDIA Corporation Recent Development
11.11 Pfizer Inc.
11.11.1 Pfizer Inc. Company Details
11.11.2 Pfizer Inc. Business Overview
11.11.3 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Introduction
11.11.4 Pfizer Inc. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.11.5 Pfizer Inc. Recent Development
11.12 Recursion Pharmaceuticals Inc.
11.12.1 Recursion Pharmaceuticals Inc. Company Details
11.12.2 Recursion Pharmaceuticals Inc. Business Overview
11.12.3 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Introduction
11.12.4 Recursion Pharmaceuticals Inc. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.12.5 Recursion Pharmaceuticals Inc. Recent Development
11.13 XtalPi Inc
11.13.1 XtalPi Inc Company Details
11.13.2 XtalPi Inc Business Overview
11.13.3 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Introduction
11.13.4 XtalPi Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
11.13.5 XtalPi Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hardware
Table 3. Key Players of Software
Table 4. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Region (2020-2025)
Table 8. Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Region (2026-2031)
Table 10. Artificial Intelligence (AI) in Pharmaceutical Market Trends
Table 11. Artificial Intelligence (AI) in Pharmaceutical Market Drivers
Table 12. Artificial Intelligence (AI) in Pharmaceutical Market Challenges
Table 13. Artificial Intelligence (AI) in Pharmaceutical Market Restraints
Table 14. Global Artificial Intelligence (AI) in Pharmaceutical Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Players (2020-2025)
Table 16. Global Top Artificial Intelligence (AI) in Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Pharmaceutical as of 2024)
Table 17. Ranking of Global Top Artificial Intelligence (AI) in Pharmaceutical Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Artificial Intelligence (AI) in Pharmaceutical Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Artificial Intelligence (AI) in Pharmaceutical, Headquarters and Area Served
Table 20. Global Key Players of Artificial Intelligence (AI) in Pharmaceutical, Product and Application
Table 21. Global Key Players of Artificial Intelligence (AI) in Pharmaceutical, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Type (2020-2025)
Table 25. Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Type (2026-2031)
Table 27. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Application (2020-2025)
Table 29. Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Application (2026-2031)
Table 31. North America Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 46. AstraZeneca LLC Company Details
Table 47. AstraZeneca LLC Business Overview
Table 48. AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Product
Table 49. AstraZeneca LLC Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 50. AstraZeneca LLC Recent Development
Table 51. Atomwise Inc Company Details
Table 52. Atomwise Inc Business Overview
Table 53. Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Product
Table 54. Atomwise Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 55. Atomwise Inc Recent Development
Table 56. Bayer AG Company Details
Table 57. Bayer AG Business Overview
Table 58. Bayer AG Artificial Intelligence (AI) in Pharmaceutical Product
Table 59. Bayer AG Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 60. Bayer AG Recent Development
Table 61. Cloud Pharmaceuticals Inc Company Details
Table 62. Cloud Pharmaceuticals Inc Business Overview
Table 63. Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Product
Table 64. Cloud Pharmaceuticals Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 65. Cloud Pharmaceuticals Inc Recent Development
Table 66. GNS Healthcare Company Details
Table 67. GNS Healthcare Business Overview
Table 68. GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Product
Table 69. GNS Healthcare Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 70. GNS Healthcare Recent Development
Table 71. IBM Watson Company Details
Table 72. IBM Watson Business Overview
Table 73. IBM Watson Artificial Intelligence (AI) in Pharmaceutical Product
Table 74. IBM Watson Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 75. IBM Watson Recent Development
Table 76. Merck & Co. Company Details
Table 77. Merck & Co. Business Overview
Table 78. Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Product
Table 79. Merck & Co. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 80. Merck & Co. Recent Development
Table 81. Microsoft Corporation Company Details
Table 82. Microsoft Corporation Business Overview
Table 83. Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Product
Table 84. Microsoft Corporation Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 85. Microsoft Corporation Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Artificial Intelligence (AI) in Pharmaceutical Product
Table 89. Novartis AG Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. NVIDIA Corporation Company Details
Table 92. NVIDIA Corporation Business Overview
Table 93. NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Product
Table 94. NVIDIA Corporation Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 95. NVIDIA Corporation Recent Development
Table 96. Pfizer Inc. Company Details
Table 97. Pfizer Inc. Business Overview
Table 98. Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Product
Table 99. Pfizer Inc. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 100. Pfizer Inc. Recent Development
Table 101. Recursion Pharmaceuticals Inc. Company Details
Table 102. Recursion Pharmaceuticals Inc. Business Overview
Table 103. Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Product
Table 104. Recursion Pharmaceuticals Inc. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 105. Recursion Pharmaceuticals Inc. Recent Development
Table 106. XtalPi Inc Company Details
Table 107. XtalPi Inc Business Overview
Table 108. XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Product
Table 109. XtalPi Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 110. XtalPi Inc Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Artificial Intelligence (AI) in Pharmaceutical Picture
Figure 2. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Type: 2024 VS 2031
Figure 4. Hardware Features
Figure 5. Software Features
Figure 6. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Institute of Biology Case Studies
Figure 10. Others Case Studies
Figure 11. Artificial Intelligence (AI) in Pharmaceutical Report Years Considered
Figure 12. Global Artificial Intelligence (AI) in Pharmaceutical Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Artificial Intelligence (AI) in Pharmaceutical Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Region: 2024 VS 2031
Figure 15. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Players in 2024
Figure 16. Global Top Artificial Intelligence (AI) in Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Pharmaceutical as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Artificial Intelligence (AI) in Pharmaceutical Revenue in 2024
Figure 18. North America Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Artificial Intelligence (AI) in Pharmaceutical Market Share by Country (2020-2031)
Figure 20. United States Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Artificial Intelligence (AI) in Pharmaceutical Market Share by Country (2020-2031)
Figure 24. Germany Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Share by Region (2020-2031)
Figure 32. China Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Artificial Intelligence (AI) in Pharmaceutical Market Share by Country (2020-2031)
Figure 40. Mexico Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Share by Country (2020-2031)
Figure 44. Turkey Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. AstraZeneca LLC Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 48. Atomwise Inc Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 49. Bayer AG Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 50. Cloud Pharmaceuticals Inc Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 51. GNS Healthcare Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 52. IBM Watson Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 53. Merck & Co. Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 54. Microsoft Corporation Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 55. Novartis AG Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 56. NVIDIA Corporation Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 57. Pfizer Inc. Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 58. Recursion Pharmaceuticals Inc. Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 59. XtalPi Inc Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hardware
Table 3. Key Players of Software
Table 4. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Region (2020-2025)
Table 8. Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Region (2026-2031)
Table 10. Artificial Intelligence (AI) in Pharmaceutical Market Trends
Table 11. Artificial Intelligence (AI) in Pharmaceutical Market Drivers
Table 12. Artificial Intelligence (AI) in Pharmaceutical Market Challenges
Table 13. Artificial Intelligence (AI) in Pharmaceutical Market Restraints
Table 14. Global Artificial Intelligence (AI) in Pharmaceutical Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Players (2020-2025)
Table 16. Global Top Artificial Intelligence (AI) in Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Pharmaceutical as of 2024)
Table 17. Ranking of Global Top Artificial Intelligence (AI) in Pharmaceutical Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Artificial Intelligence (AI) in Pharmaceutical Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Artificial Intelligence (AI) in Pharmaceutical, Headquarters and Area Served
Table 20. Global Key Players of Artificial Intelligence (AI) in Pharmaceutical, Product and Application
Table 21. Global Key Players of Artificial Intelligence (AI) in Pharmaceutical, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Type (2020-2025)
Table 25. Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Type (2026-2031)
Table 27. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Application (2020-2025)
Table 29. Global Artificial Intelligence (AI) in Pharmaceutical Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Application (2026-2031)
Table 31. North America Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (2026-2031) & (US$ Million)
Table 46. AstraZeneca LLC Company Details
Table 47. AstraZeneca LLC Business Overview
Table 48. AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Product
Table 49. AstraZeneca LLC Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 50. AstraZeneca LLC Recent Development
Table 51. Atomwise Inc Company Details
Table 52. Atomwise Inc Business Overview
Table 53. Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Product
Table 54. Atomwise Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 55. Atomwise Inc Recent Development
Table 56. Bayer AG Company Details
Table 57. Bayer AG Business Overview
Table 58. Bayer AG Artificial Intelligence (AI) in Pharmaceutical Product
Table 59. Bayer AG Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 60. Bayer AG Recent Development
Table 61. Cloud Pharmaceuticals Inc Company Details
Table 62. Cloud Pharmaceuticals Inc Business Overview
Table 63. Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Product
Table 64. Cloud Pharmaceuticals Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 65. Cloud Pharmaceuticals Inc Recent Development
Table 66. GNS Healthcare Company Details
Table 67. GNS Healthcare Business Overview
Table 68. GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Product
Table 69. GNS Healthcare Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 70. GNS Healthcare Recent Development
Table 71. IBM Watson Company Details
Table 72. IBM Watson Business Overview
Table 73. IBM Watson Artificial Intelligence (AI) in Pharmaceutical Product
Table 74. IBM Watson Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 75. IBM Watson Recent Development
Table 76. Merck & Co. Company Details
Table 77. Merck & Co. Business Overview
Table 78. Merck & Co. Artificial Intelligence (AI) in Pharmaceutical Product
Table 79. Merck & Co. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 80. Merck & Co. Recent Development
Table 81. Microsoft Corporation Company Details
Table 82. Microsoft Corporation Business Overview
Table 83. Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Product
Table 84. Microsoft Corporation Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 85. Microsoft Corporation Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Artificial Intelligence (AI) in Pharmaceutical Product
Table 89. Novartis AG Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. NVIDIA Corporation Company Details
Table 92. NVIDIA Corporation Business Overview
Table 93. NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Product
Table 94. NVIDIA Corporation Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 95. NVIDIA Corporation Recent Development
Table 96. Pfizer Inc. Company Details
Table 97. Pfizer Inc. Business Overview
Table 98. Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Product
Table 99. Pfizer Inc. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 100. Pfizer Inc. Recent Development
Table 101. Recursion Pharmaceuticals Inc. Company Details
Table 102. Recursion Pharmaceuticals Inc. Business Overview
Table 103. Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Product
Table 104. Recursion Pharmaceuticals Inc. Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 105. Recursion Pharmaceuticals Inc. Recent Development
Table 106. XtalPi Inc Company Details
Table 107. XtalPi Inc Business Overview
Table 108. XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Product
Table 109. XtalPi Inc Revenue in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025) & (US$ Million)
Table 110. XtalPi Inc Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Artificial Intelligence (AI) in Pharmaceutical Picture
Figure 2. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Type: 2024 VS 2031
Figure 4. Hardware Features
Figure 5. Software Features
Figure 6. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Institute of Biology Case Studies
Figure 10. Others Case Studies
Figure 11. Artificial Intelligence (AI) in Pharmaceutical Report Years Considered
Figure 12. Global Artificial Intelligence (AI) in Pharmaceutical Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Artificial Intelligence (AI) in Pharmaceutical Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Region: 2024 VS 2031
Figure 15. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Players in 2024
Figure 16. Global Top Artificial Intelligence (AI) in Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Pharmaceutical as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Artificial Intelligence (AI) in Pharmaceutical Revenue in 2024
Figure 18. North America Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Artificial Intelligence (AI) in Pharmaceutical Market Share by Country (2020-2031)
Figure 20. United States Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Artificial Intelligence (AI) in Pharmaceutical Market Share by Country (2020-2031)
Figure 24. Germany Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Artificial Intelligence (AI) in Pharmaceutical Market Share by Region (2020-2031)
Figure 32. China Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Artificial Intelligence (AI) in Pharmaceutical Market Share by Country (2020-2031)
Figure 40. Mexico Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Artificial Intelligence (AI) in Pharmaceutical Market Share by Country (2020-2031)
Figure 44. Turkey Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Artificial Intelligence (AI) in Pharmaceutical Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. AstraZeneca LLC Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 48. Atomwise Inc Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 49. Bayer AG Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 50. Cloud Pharmaceuticals Inc Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 51. GNS Healthcare Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 52. IBM Watson Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 53. Merck & Co. Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 54. Microsoft Corporation Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 55. Novartis AG Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 56. NVIDIA Corporation Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 57. Pfizer Inc. Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 58. Recursion Pharmaceuticals Inc. Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 59. XtalPi Inc Revenue Growth Rate in Artificial Intelligence (AI) in Pharmaceutical Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232